Abstract
Interleukin 1 (IL 1), previously known as lymphocyte-activating factor (LAF), is key mediator of macrophage function. Macrophages release IL 1 following stimulation with bacterial endotoxin (Gery and Waks-man, 1972), substances that possess adjuvant properties (Oppenheim et al., 1980), or phagocytic stimuli (Rosenwasser et al., 1979). IL 1 can completely replace macrophages in some in vitro immunological assay systems (Maizel et al., 1981) and greatly reduce the number of macrophages required in other systems (Rosenberg and Lipsky, 1981). IL 1 probably replaces the soluble activating factor released by macrophages but cannot replace the macrophage function of antigen or lectin presentation (Rosenberg and Lipsky, 1981). IL 1 may also regulate nonimmunological responses that involve macrophages. Specifically, IL 1 may be identical to the fever-producing substance endogenous pyrogen (Murphy et al., 1980; Rosenwasser et al., 1979), and appears to stimulate prostaglandin and collagenase release from synovial cells (Mizel et al., 1981) and to release acute-phase reactants (Selinger et al., 1980).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bernheim, H. A., Block, L. H., Francis, L., and Atkins, E., 1980, Release of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes, J. Exp. Med. 152:1811.
Diamanstein, T., Klos, M., and Reiman, J., 1981, Studies on T-lymphocyte activation. I. Is competence induction in thymocytes by phorbol myristate acetate an accessory cell-independent event?, Immunology 43:183.
English, D., and Anderson, B. R., 1974, Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque, J. Immunol. Methods 5:249.
Farrar, J. J., Simon, P. L., Farrar, W. L., Koopman, W. J., and Fullar-Bonar, J., 1979, Role of mitogenic factor, lymphocyte-activating factor and immune interferon in the induction of humoral and cell-mediated immunity, Ann. N.Y. Acad. Sci. 332:303.
Fumarola, D., and Jirillo, E., 1979, Endotoxin contamination of some commercial preparations used in experimental research, in: Biomedical Applications of the Horseshoe Crab, pp. 379–385, Liss, New York.
Gery, I., and Waksman, B. H., 1972, Potentiation of T-lymphocyte response to mitogens. II. The cellular source of potentiating mediators, J. Exp. Med. 136:143.
Hanson, D. F., Murphy, P. A., and Windle, B. E., 1980, Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci, J. Exp. Med. 151: 1360.
Kampschmidt, R. F., and Upchurch, H. F., 1980, Neutrophil release after injection of endotoxin or leukocytic endogenous mediator into rats, J. Reticuloendothelial Soc. 28:191.
Lachman, L. B., and Metzgar, R. S., 1980a, Purification and characterization of human lymphocyte activating factor, in: Biochemical Characterization of Lymphokines (A. L. deWeck, F. Kristensen, and M. Landy, eds.), pp. 397–398, 405–409, Academic Press, New York.
Lachman, L. B., and Metzgar, R. S., 1980b, Characterization of high and low molecular weight lymphocyte activating factor (interleukin 1) from P388D1 and J774.1 mouse macrophage cell lines, J. Reticuloendothelial Soc. 27:621.
Lachman, L. B., Hacker, M. P., Blyden, G. T., and Handschumacher, R. E., 1977, Preparation of lymphocyte activating factor from continuous murine macrophage cell lines, Cell. Immunol. 34:416.
Lachman, L. B., Moore, J. O., and Metzgar, R. S., 1979, Preparation and characterization of lymphocyte activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells, Cell. Immunol. 41:199.
Lachman, L. B., Page, S. O., and Metzgar, R. S., 1980, Purification of human interleukin, I, J. Supramol. Struct. 13:457.
Lachman, L. B., George, F. W., IV, and Metzgar, R. S., 1981, Human interleukin 1 and 2: Purification and characterization, in: Lymphokines and Thymic Factors (A. L. Goldstein and M. A. Chirigos, eds.), pp. 21–32, Raven Press, New York.
Larrick, J. W., Fisher, D. G., Anderson, S. J., and Koren, H. S., 1980, Characterization of a human macrophage-like cell line stimulated in vitro: A model of macrophage functions, J. Immunol. 125:6.
Larsson, E.-L., and Coutinho, A., 1980, Mechanism of T cell activation. I. A screening of “step one” ligands, Eur. J. Immunol. 10:93.
Levin, N., Hatcher, V. B., and Lazarus, G. S., 1976, Proteinases of human epidermis: A possible mechanism for polymorphonuclear leukocyte Chemotaxis, Biochim. Biophys. Acta 452:458.
Maizel, A. L., Mehta, S. R., Ford, R. J., and Lachman, L. B., 1981, Effect of interleukin 1 on human thymocytes and purified human T cells, J. Exp. Med. 153:470.
Männel, D. N., Farrar, J. J., and Mergenhagen, S. E., 1980, Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells, J. Immunol. 124: 1106.
Mizel, S. B., and Mizel, D., 1981, Purification to apparent homogeneity of murine interleukin 1, J. Immunol. 126:834.
Mizel, S. B., Rosenstreich, D. L., and Oppenheim, J. J., Phorbol myristic acetate stimulates LAF production by the macrophage cell line P388D1, Cell. Immunol. 40:230.
Mizel, S. B., Dayer, J. M., Krane, S. M., and Mergenhagen, S. E., 1981, Stimulation or rhuematoid synovial cell collegenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1), Proc. Xatl. Acad. Sci. USA 78:2474.
Moore, R. N., Oppenheim, J. J., Farrar, J. J., Carter, C. S., Jr., Waheed, A., and Shadduck, R. K., 1980, Production of lymphocyte-activating factor (interleukin 1) by macrophages activated with colony-stimulating factors, J. Immunol. 125:1302.
Morgan, D. A., Ruscetti, F. W., and Gallo, R. C., 1976, Selective in vitro growth of T lymphocytes from normal human bone marrows, Science 193:1007.
Morrison, D. C., and Jacobs, D. M., 1976, Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B, Infect. Immun. 13:298.
Murphy, P. A., Simon, P. L., and Willoughby, W. F., 1980, Endogenous pyrogens made by rabbit alveolar macrophages, J. Immunol. 124:2498.
Oakley, B. R., Kirsch, D. R., and Morris, N. R., 1980, A simple ultra-sensitive silver stain for detecting proteins in Polyacrylamide gels, Anal. Biochem. 105:361.
Oppenheim, J. J., Togawa, A., Chedid, L., and Mizel, S., 1980, Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor, Cell. Immunol. 50:71.
Otterness, I. G., Lachman, L. B., and Bliven, M. L., 1981, Effects of levamisole on the proliferation of thymic lymphocyte subpopulations, Immunopharmacology 3:61.
Rosenberg, A. S., and Lipsky, P. E., 1981, The role of monocytes in pokeweed mitogen-stimulated human B cell activation: Separate requirements for intact monocytes and a soluble monocyte factor, J. Immunol. 126:1341.
Rosenstreich, D. L., and Mizel, S. B., 1979, Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate, J. Immunol. 123:1749.
Rosenwasser, L. J., Dinarello, C. A., and Rosenthal, A. S., 1979, Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen, J. Exp. Med. 150:709.
Selinger, M. J., McAdams, K. P., Kaplan, M. M., Sipe, J. D., Vogel, S. N., and Rosenstreich, D. L., 1980, Monokine induced synthesis of serum amyloid A protein by hepatocytes, Sature (London) 285:498.
Smith, K. A., Lachman, L. B., Oppenheim, J. J., and Favata, M. F., 1980, The functional relationship of the intcrleukins, J. Exp. Med. 151:1551.
Togowa, A., Oppenheim, J. J., and Mizel, S. B., 1979, Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: Biochemical relationship of high and low molecular weight forms of LAY, J. Immunol. 122:2112.
Wood, D. D., and Cameron, P. M., 1978, The relationship between bacterial endotoxin and human B cell-activating factor, J. Immunol. 121:53.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Lachman, L.B. (1983). Interleukin 1. In: Nowotny, A. (eds) Beneficial Effects of Endotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4364-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4364-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4366-0
Online ISBN: 978-1-4684-4364-6
eBook Packages: Springer Book Archive